London Daily

Focus on the big picture.
Wednesday, Oct 01, 2025

Russia wants to win the race for the coronavirus vaccine

Russia wants to win the race for the coronavirus vaccine

Moscow researchers say one of the country's possible coronavirus vaccines has proven safe in small-scale human trials and is ready for further testing.
Some might say it's a modest victory for a country that has sought for years to restore the reputation of having cutting-edge science of the Soviet era, and for President Vladimir Putin.

However, on Thursday, Britain, the United States and Canada accused Russia of hacking data from international research centers that are trying to develop a vaccine.

The Kremlin denies any involvement, while the head of the country's sovereign wealth fund called the allegations an attempt to tarnish the Russian investigative effort.

It remains an accusation that jeopardizes the desired drive for prestige inoculation.

Old school vaccine diplomacy could help. Even in the depths of the Cold War, Soviet and American doctors worked collaboratively to combat polio, and later smallpox.

Russia is also not the only nation desperate to find a quick solution, and preferably first.

However, the pressure there is acute. Putin needs to boost his deteriorating popularity, despite the overwhelming approval of a plebiscite this month that approved constitutional changes, which could keep him in power until 2036.

The need has only increased with massive protests in the western city of Khabarovsk, after the local governor's arrest last week.

The covid-19 outbreak has been intense in Russia, which has the fourth highest number of cases worldwide.

Mortality rates have been remarkably low, but new cases continue to rise at a rate of more than 6,000 per day.

The economy has been hit hard. However, efforts to develop a vaccine are as much about regaining a status tarnished by years of low investment, a dramatic exodus of professionals, and last year's accusations of plagiarism and other unethical practices that led to the removal of hundreds of items. academics.

Even before the coronavirus, innovation and science were cornerstones of the $400 billion development plan that Putin hopes to leave as a legacy. Unfortunately, time pressure and patriotism don't always produce the best results.

For now, what we know of Russia's vaccine effort is encouraging.

Sechenov University is testing a vaccine developed by the Gamaleya Institute of Epidemiology and Microbiology in Moscow, and is preparing to discharge its latest volunteers after the initial phase of the study.

He recorded an immune response and found that the prototype was safe. The military, who conducted a parallel study, have made similar comments and released their own volunteers.

Russia is not as advanced as AstraZeneca Plc and the University of Oxford or Chinese researchers, but it has more than a dozen promising vaccine candidates, and Gamaleya is among the favorites, along with prototypes developed by the Vector Institute in Siberia, formerly the Soviet Biological Weapons Research Center.

However, there are still many things that we will not know. The data from the first phase of the Gamaleya trial is not yet public and further testing will be required.

The third and final phase, which tests the vaccine's actual effectiveness in a larger universe, would normally take anywhere from six months to a year.

It is not even clear whether Russia, which is no longer a major exporter of vaccines, can manufacture enough.

However, this has not dampened enthusiasm in the state media or acts of bravery like that of Gamaleya researchers who voluntarily injected themselves with the untested prototype.

Practices such as recruiting volunteers for the Gamaleya study among employees of the state-owned Sberbank PJSC appealing to their patriotism are no less worrisome.

Or simplified methods, as in a vague Moscow study that encouraged doctors to try the antimalarial drug hydroxychloroquine. Piracy charges make matters worse.

If Russia wants to reap the diplomatic and political benefits of a local vaccine, it needs a victory to be credible, at home and abroad.

Following international standards and collaborating would be a start. In fact, Putin may have no choice: Large-scale testing may be required in countries where the infection rate is highest.

It will not yet come naturally to Putin's nationalist administration, which has long struggled to reconcile aspirations for scientific glory with a determination to tighten control.

The Kremlin has tried to monitor contacts with foreign investigators, and several academics with ties abroad have been charged with treason. Other governments will now be more cautious as well.

However, history suggests that it can be done successfully, with the United States and other countries.

Peter Hotez of Baylor College of Medicine, who has served as a scientific envoy to former United States President Barack Obama and who has written extensively on the subject, particularly highlights the cooperation between American physician Albert Sabin and Soviet virologist Mikhail Chumakov on the vaccine. oral against polio in the late 1950s.

Relations had thawed shortly after Josef Stalin's death, but they were still tense and competitive: Sputnik was launched in 1957. Both sides wanted to steal technological secrets.

Still, a few years later, there was collaboration again when Soviet scientists pioneered a freeze-drying technique for the smallpox vaccine.

Unfortunately, the environment today might be too 'toxic'.
Newsletter

Related Articles

0:00
0:00
Close
Trump Administration Launches “TrumpRx” Plan to Enable Direct Drug Sales at Deep Discounts
Trump Announces Intention to Impose 100 Percent Tariff on Foreign-Made Films
Altman Says GPT-5 Already Outpaces Him, Warns AI Could Automate 40% of Work
Singapore and Hong Kong Vie to Dominate Asia’s Rising Gold Trade
Trump Organization Teams with Saudi Developer on $1 Billion Trump Plaza in Jeddah
Manhattan Sees Surge in Office-to-Housing Conversions, Highest Since 2008
Switzerland and U.S. Issue Joint Assurance Against Currency Manipulation
Electronic Arts to Be Taken Private in Historic $55 Billion Buyout
Thomas Jacob Sanford Named as Suspect in Deadly Michigan Church Shooting and Arson
Russian Research Vessel 'Yantar' Tracked Mapping Europe’s Subsea Cables, Raising Security Alarms
New York Man Arrested After On-Air Confession to 2017 Parents’ Murders
U.S. Defense Chief Orders Sudden Summit of Hundreds of Generals and Admirals
Global Cruise Industry Posts Dramatic Comeback with 34.6 Million Passengers in 2024
Trump Claims FBI Planted 274 Agents at Capitol Riot, Citing Unverified Reports
India: Internet Suspended in Bareilly Amid Communal Clashes Between Muslims and Hindus
Supreme Court Extends Freeze on Nearly $5 Billion in U.S. Foreign Aid at Trump’s Request
Archaeologists Recover Statues and Temples from 2,000-Year-Old Sunken City off Alexandria
China Deploys 2,000 Workers to Spain to Build Major EV Battery Factory, Raising European Dependence
Speed Takes Over: How Drive-Through Coffee Chains Are Rewriting U.S. Coffee Culture
U.S. Demands Brussels Scrutinize Digital Rules to Prevent Bias Against American Tech
Ringo Starr Champions Enduring Beatles Legacy While Debuting Las Vegas Art Show
Private Equity’s Fundraising Surge Triggers Concern of European Market Shake-Out
Colombian President Petro Vows to Mobilize Volunteers for Gaza and Joins List of Fighters
FBI Removes Agents Who Kneeled at 2020 Protest, Citing Breach of Professional Conduct
Trump Alleges ‘Triple Sabotage’ at United Nations After Escalator and Teleprompter Failures
Shock in France: 5 Years in Prison for Former President Nicolas Sarkozy
Tokyo’s Jimbōchō Named World’s Coolest Neighbourhood for 2025
European Officials Fear Trump May Shift Blame for Ukraine War onto EU
BNP Paribas Abandons Ban on 'Controversial Weapons' Financing Amid Europe’s Defence Push
Typhoon Ragasa Leaves Trail of Destruction Across East Asia Before Making Landfall in China
The Personality Rights Challenge in India’s AI Era
Big Banks Rebuild in Hong Kong as Deal Volume Surges
Italy Considers Freezing Retirement Age at 67 to Avert Scheduled Hike
Italian City to Impose Tax on Visiting Dogs Starting in 2026
Arnault Denounces Proposed Wealth Tax as Threat to French Economy
Study Finds No Safe Level of Alcohol for Dementia Risk
Denmark Investigates Drone Incursion, Does Not Rule Out Russian Involvement
Lilly CEO Warns UK Is ‘Worst Country in Europe’ for Drug Prices, Pulls Back Investment
Nigel Farage Emerges as Central Force in British Politics with Reform UK Surge
Disney Reinstates ‘Jimmy Kimmel Live!’ after Six-Day Suspension over Charlie Kirk Comments
U.S. Prosecutors Move to Break Up Google’s Advertising Monopoly
Nvidia Pledges Up to $100 Billion Investment in OpenAI to Power Massive AI Data Center Build-Out
U.S. Signals ‘Large and Forceful’ Support for Argentina Amid Market Turmoil
Nvidia and Abu Dhabi’s TII Launch First AI-&-Robotics Lab in the Middle East
Vietnam Faces Up to $25 Billion Export Loss as U.S. Tariffs Bite
Europe Signals Stronger Support for Taiwan at Major Taipei Defence Show
Indonesia Court Upholds Military Law Amid Concerns Over Expanded Civilian Role
Larry Ellison, Michael Dell and Rupert Murdoch Join Trump-Backed Bid to Take Over TikTok
Trump and Musk Reunite Publicly for First Time Since Fallout at Kirk Memorial
Vietnam Closes 86 Million Untouched Bank Accounts Over Biometric ID Rules
×